We examined the effects of activation of endothelial protein kinase C (PKC) of the endothelial barrier function. Exposure of confluent bovine pulmonary artery endothelial cell monolayers to phorbol 12-myristate 13-acetate (PMA) resulted in concentration-dependent (10-s-10-6 M) increases in PKC activity and in the transendothelial flux of 25I-albumin. Exposure of the endothelium to 1-oleoyl 2-acetyl glycerol (OAG) also increased the transendothelial flux of 11I-albumin in a concentration-dependent manner. Neither 4a-phorbol didecanoate nor 1-mono-oleoyl glycerol, which do not activate PKC, altered permeability. The increase in '25I-albumin permeability induced by PMA was inhibited by 25 gM H7 (a PKC inhibitor), but not by the control compound HA1004 (25 MM). After 16 h of exposure to PMA, '25I-albumin permeability returned to baseline and a significant reduction in cytosolic PKC activity was noted. Further challenge with PMA at this time resulted in no significant increase in PKC activity indicating downregulation of the enzyme; moreover, this PMA challenge did not increase endothelial permeability. Exposure of endothelial monolayers to phospholipase C (PLC), which increases membrane phosphatidylinositide turnover, or to a-thrombin also induced concentration-dependent activation of PKC and increases in "5I-albumin endothelial permeability. The thrombin-and PLC-induced permeability increases were inhibited by H7, but not by HA1004. The activation of endothelial PKC directly by PMA or OAG and by PLC and a-thrombin increases the transendothelial albumin permeability, indicating that PKC activation is an important signal transduction pathway by which extracellular mediators increase endothelial macromolecular transport. (J.
Introduction
Increased pulmonary vascular permeability is a characteristic feature of inflammatory lung injury (1) , including the adult respiratory distress syndrome (2) . Increases in vascular permeability are noted in response to a variety of inflammation-pro- Receivedfor publication 16 December 1988 and in revisedform 28 November 1989. intravascular coagulation (5) , fat embolism (6) , and oxygen radicals (7) . Morphological and functional studies of endotheHal cells show characteristic similarities in the response to various inflammatory mediators (8, 9) ; (a) increase in endothelial permeability to macromolecules (3, 10) , (b) a change in the shape of endothelial cells (i.e., a "rounding up" of endothelial cells) (1 1), and (c) activation of second messenger systems secondary to the breakdown of membrane phospholipids and generation of inositol phosphates and 1 ,2-diacylglycerol (12) .
The relationship between the activation of these second messenger pathways and the increase in endothelial permeability remains unclear. The activation of protein kinase C (PKC),' which can occur as a result of the generation of 1,2-diacylglycerol (13) , decreases transepithelial resistance (14) , suggesting that second messengers regulate the epithelial barrier transport via a PKC-dependent pathway. The loss of epithelial barrier function secondary to PKC activation is associated with the phosphorylation of specific cytoskeletal proteins (15) and decreased cell-cell contacts (15, 16) . Endothelial cell barrier function, which is also the result of cell-cell interactions, may be modified by second messenger pathways (17) via the activation of PKC. In this study, we postulated that activation of PKC mediates the altered endothelial barrier function seen in response to extracellular mediators.
We present evidence that the activation of endothelial PKC using either phorbol 12-myristate 13 -acetate (a phorbol ester) or l-oleoyl 2-acetyl glycerol (a 1,2-diacylglycerol analogue) resulted in PKC activation and increase in the transendothelial flux of '25I-albumin, which is not due to cytolysis. The exposure of endothelial monolayers to phospholipase C, a membrane phosphodiesterase, which hydrolyzes phosphatidylinositides to 1 ,2-diacylglycerol (18) , also increased PKC activity and transendothelial '25I-albumin permeability in a concentration-dependent manner. Moreover, the permeabilityincreasing effect of a-thrombin (3) , an extracellular mediator, is mediated in part by the activation of endothelial PKC. The results of this study indicate that the activation of endothelial PKC, subsequent to increased phosphatidylinositol turnover, is a common pathway by which mediators increase transendothelial permeability during tissue inflammation.
Methods
Preparation ofendothelial monolayers. Bovine pulmonary artery endothelial cells were removed from the main pulmonary artery after incubation with 0.65% collagenase, seeded on 60-mm petri dishes, and grown to confluence. The cells were identified as being endothelial, without contaminating fibroblasts or smooth muscle cells, using phase contrast microscopy, presence of Factor VIII-related antigen as dem-onstrated by indirect immunofluorescence, uptake of acylated low density lipoproteins, presence of angiotensin-converting enzyme, and electron microscopic appearance (19) . At five to seven population doublings, the endothelial monolayer was removed using 0.025% trypsin and centrifuged (100 g; 5 min). The cells (8 X IO' cells/ml) were resuspended in Dulbecco's modified Eagle medium (DME) and seeded as described below.
2II-albumin endothelial permeability assay. Polycarbonate micropore membranes (13-mm diam; 0.8-Mm pore size; Nuclepore Corp., Pleasanton, CA) were gelatinized (type II calf skin gelatin; Sigma Chemical Co., St. Louis, MO) as previously described (3), mounted on plastic cylinders (9 mm i.d.; Adaps, Dedham, MA), and sterilized by ultraviolet light for 24 h. Endothelial cells (2 X lIO in 0.25 ml of DME) were then seeded to the gelatinized membranes and cultured for 4 d (370C; 5% CO2) to allow the cells to develop confluency. The confluent monolayer demonstrated the typical cobblestone appearance.
The experimental apparatus for the study oftransendothelial transport in the absence of hydrostatic and oncotic pressure gradients has been described (3). In brief, the system consists of two compartments that communicate solely by a microporous polycarbonate membrane lined with the endothelial cell monolayer as described above. The luminal (upper) compartment (0.7 ml capacity) was suspended in the abluminal (lower) compartment (25 ml capacity). The lower compartment was stirred continuously for complete mixing. The entire system was kept in a water bath at a constant temperature of 370C. The fluid height in both compartments was the same to eliminate convective flux.
Hanks' balanced salt solution (HBSS) containing 0.5% bovine serum albumin (Sigma Chemical Co.) and 20 mM Hepes buffer was used on both sides of the monolayer. Albumin labeled with '25I (New England Nuclear, Boston, MA) using the chloramine-t method (20) was added to the upper compartment. 125I-albumin was extensively dialyzed against KI before use; the free 1251 was always less than 1%. A maximum of 1.0 mCi in 0.7 ml ofHBSS was added per well. Two 25-Ml samples were taken at the beginning of each study to determine the initial radioactivity of the upper compartment. Samples were taken from the lower compartment every 5 min for 30 min before the interventions, and then for 30 min after the interventions. The interventions were added to the upper compartment mixed in 50 Ml of HBSS. The radioactivity of the samples was measured in a gamma counter (United Technologies Packard, Sterling, VA). The clearance rates of '25I-albumin was determined by least squares linear regression for the control and experimental groups (21) .
Assay ofprotein kinase C activity. 10 ,000 g for I h. The supernatant (the cytosolic fraction) was saved and the pellet was resuspended to the original volume in extraction buffer containing 50 mM Tris-HCl, pH 7.5; 50 mM 2-ME; I mM PMSF, and 2 mM EGTA with 0.1% Triton X-100. These samples were again subjected to homogenization and ultracentrifugation for 1 h. This supernatant (containing the soluble membrane fraction) was also saved and the pellet was discarded. Preliminary studies confirmed that minimal phospholipid-dependent activity existed in the insoluble membrane extracts. Cytosolic and soluble membrane extracts were subjected to DEAE-cellulose ion exchange chromatography as described previously (24) . All fractions were stored at -700C and assayed within 24 h. The standard assay mixture (100 ,ul) contained assay buffer (35 mM Tris-HC1, pH 7.5; 2 mM 2-ME; 1.0 mM PMSF; 0.01% Triton X-100; 0.4 mM EGTA; 0.4MM EDTA: 5 mM MgCI2; 1.5 mM CaCI2); 50,gM ATP; 32P-ATP (200-500 cpm/pmol); and histone Hl (25 Mg/assay); with or without activators (10 Mg phosphatidylserine and 25 Mg 1,2-diolein). Phosphatidylserine, 1,2-diolein, 2-ME, and PMSF were prepared freshly on the day of assay. The amount of cell fraction to be added was determined before assay using the equivalent activity of 10
Mg of cell protein before DEAE-cellulose chromatography by the Lowry method (25), which was nearly constant at 10 Mg/IO Ml per assay. Incubations were carried out at 370C for 5 min. The reaction was stopped by the addition ofa 1,000-fold excess ofunlabeled ice-cold ATP and the entire assay mixture was pipetted onto a 2 X 2 cm square of phosphocellulose filter paper P-8 1; Whatman, Inc., Englewood Cliffs, NJ). The filters were then washed thrice with 10% TCA with 20 mM Na-pyrophosphate, once with isopropanol, and allowed to air dry. Individual filters were quantified by counting in a Tricarb 2000CA Liquid Scintillation Analyzer (United Technologies Packard). Assays were made in triplicate and in the presence and absence of the activators (phosphatidylserine and 1,2-diolein). Activity was expressed as "units" of kinase activity (picomoles of 32p incorporated per minute per milligram of protein fraction added per milligram histone used [pmol/mg/mg/min]). Net PKC activity was the value obtained by subtracting the kinase activity measured in the absence of activators from the activity measured in the presence of activators. Although absolute quantities of kinase recovery varied among cell batches, controls were performed for each group of interventions and these were consistent within each batch.
Interventions. Interventions used in the permeability and PKC assays were: (a) PMA, (b) 4a-phorbol 12,13-didecanoate (4a-PDD), (c) l-oleoyl 2-acetyl glycerol (OAG), (d) l-mono-oleoyl glycerol (MOG), (e) phospholipase C, (f) purified human a-thrombin (prepared by Dr. John Fenton, the New York State Department of Health and the Albany Medical College, Albany, NY, as described by him [26] ), and (g) dimethyl sulfoxide (DMSO) as control. These reagents (except athrombin) were obtained from Sigma Chemical Co. The lipids (OAG and MOG) were ultrasonically dispersed into HBSS immediately before addition to the endothelial mwnolayer. The effects of varying concentrations of the interventions indicated above were studied.
Inhibition of PKC. Bovine pulmonary artery endothelial monolayers were preincubated (30 min; 37°C; 5% C02; pH of 7.4) with DME containing either the isoquinolinylsulfonamide derivative H7 (an inhibitor of PKC [27] ) or HA 1004 (as the control agent [27] 16 -h incubation period, both the PMAchallenged and control groups were treated with either PMA (l0-7 M) or vehicle for 5 min, and 251I-albumin permeability was assayed as described above.
To assess whether PMA treatment resulted in PKC downregulation, PMA (final concentration l0-7 M) in DMSO in HBSS was pipetted into the roller bottles containing the pulmonary artery endothelial cell monolayers. At the end of the 16-h incubation period, the PMAchallenged groups were treated with either PMA (10-7 M) or with the vehicle for 5 min as above. The cytosolic and membrane-bound PKC activities were assessed as described previously.
Assay oflactate dehydrogenase (LDH) release. LDH release from bovine pulmonary artery endothelial monolayers was determined (28) . The bovine pulmonary artery endothelial monolayers were prepared as above, except that the cells were seeded onto plastic tissue culture plates (Gibco Laboratories). All experiments were made in triplicate, using an LDH Assay Kit (Sigma Chemical Co.) and Beckman DU-50 spectrophotometer to measure LDH release (Beckman Instruments, Inc., Fullerton, CA). Specific release was determined at baseline and after 4 h of exposure to PMA (10-6 M) and the results were compared to total LDH determined after cell lysis using 1% Triton X-100 (Fisher Scientific Co., Springfield, NJ). Statistical analysis. Changes in '25I-albumin clearance across BPAE were analyzed using analysis of variance (ANOVA). Significance of the changes (set at P < 0.05) was determined by Student's t test.
Results
Activation of endothelial PKC and its effect on endothelial monolayer permeability. The activity of PKC in confluent bovine pulmonary artery endothelial cells was studied before and after exposure to increasing concentrations of the lipophilic phorbol ester, PMA (Fig. 1 a) . Quiescent monolayers exhibited PKC activity predominantly in the cytosolic fraction, with only negligible activity in the membrane fraction (Fig. 1 a) . Exposure ofbovine pulmonary artery endothelial cells to PMA for 5 min resulted in a characteristic concentration-dependent decrease in cytosolic PKC activity and increase in the membrane-associated PKC activity (Fig. 1 a) .
Exposure of bovine pulmonary artery endothelial cells to PMA induced concentration-dependent increases in the 12511 albumin clearance rates compared with DMSO control (Fig. 1  b) . A maximal increase in 125I-albumin clearance rate of 92±18% above baseline was observed at PMA concentration of 10-6 M. Increases in '251I-albumin clearance rates occurred within 5 min of exposure, and remained elevated for the 30-min duration of the assay. Exposure of bovine pulmonary artery endothelial cells to 10-6 M 4a-phorbol didecanoate, a phorbol ester that does not activate PKC (29), did not increase permeability compared to the DMSO vehicle control (Fig. 1  b) . The correlation between the PMA-induced activation of PKC and the increases in permeability mediated by PMA is shown in Fig. 2 . The clearance rate of '251I-albumin increased with increases in the membrane-associated PKC activity (Fig. 2) . Release of LDH from bovine pulmonary artery endothelial monolayers was determined at baseline and after exposure to 10-6 M PMA to assess whether the highest concentration of PMA caused endothelial cell lysis. LDH release was not significantly increased above baseline after exposure to PMA for up to 4 h (Table I) .
Effect ofOAG on endothelial permeability. The diacylglycerol PKC activator, OAG (10-5 and 10-4 M), increased transendothelial '25I-albumin clearance rates compared to baseline values, whereas exposure to MOG, a monoacylglycerol which does not activate PKC, did not increase '25I-albumin clearance rates above baseline values (Fig. 3) .
Effect ofinhibition ofPKC activation on endothelialpermeability increases. The effects of the isoquinolinylsulfonamide inhibitor H7 and the control isoquinolinylsulfonamide HA 1004 on PKC activity are shown in Fig. 4 a. In the preparations of purified cytosolic protein extracts, the H7 concentration of 25 MuM significantly inhibited the phospholipid-dependent kinase activity, whereas HA 1004 was ineffective at the concentration of 25 MAM (Fig. 4 a) . Both compounds were ineffective at 10 MM but effective inhibitors at 50 MM; therefore, we used H7 and HA1004 each at concentration of 25 MM for these studies. The effects of preincubating bovine pulmonary artery endothelial monolayers with 25 MAM H7 are shown in Fig. 4 b. The increase in '25I-albumin permeability observed after exposure to 1O-7 M PMA was significantly reduced, whereas preincubation with 25 MM HA 1004 did not prevent the increase in permeability mediated by PMA (Fig. 4 b) .
Time course ofthe PMA effect. (Fig. 5 b) . A 16-h incubation with PMA (10-7 M) followed by 5 min incubation with vehicle resulted in a marked decrease in cytosolic PKC activity (Table II) . Moreover, PKC activity was not translocated to the membrane fraction after Values represent the mean±SEM of three experiments. *P < 0.05 compared to control; **P < 0.05 compared to PMA response.
the prolonged PMA treatment, indicating that PKC was not persistently activated. This is in contrast to PKC activation observed after acute exposure to PMA (Fig. 1 a) . A 16-h incubation with PMA (10-7 M) followed by 5 min challenge with PMA (10-v M) also did not result in translocation of PKC activity to the membrane-bound fraction, further indicating that PKC was depleted following PMA treatment regimen used in the present study.
Effects ofphospholipase C (PLC). We investigated whether increased phosphotidylinositide turnover induced by PLC would activate endothelial cell PKC and also increase endothelial monolayer permeability to '25I-albumin. Concentrationdependent increases in '25I-albumin clearance rates were noted after exposure of the endothelial monolayer to PLC (Fig. 6 a) . PLC (1 U/ml) also activated endothelial cell PKC compared to control (Fig. 6 b) . The PLC-mediated increase in permeability 1994
Lynch, Ferro, Blumenstock, Brockenauer, and Malik (Fig. 6 c) . This concentration range of PLC (0.1-10 U/ml) did not result in endothelial LDH release, indicating that the permeability increase was not due to cytolysis. Effects of at-thrombin. Addition of a-thrombin to bovine pulmonary artery endothelial monolayers resulted in concentration-dependent increases in '251I-albumin clearance rates (Fig. 7 a) confirming our previous findings (3). Exposure ofthe endothelial monolayer to a-thrombin also produced concentration-dependent PKC activation (Fig. 7 b) . Preincubation of endothelial cells with H7 (25 ,uM) before the addition of athrombin (10-8 M) significantly reduced the as-thrombin-mediated increase in endothelial permeability to 1251-albumin, whereas HA 1004 was not protective (Fig. 7 c) . 
Discussion
In the present study, we have shown that the activation of endothelial cell PKC by various interventions leads to increases in endothelial permeability to albumin. This conclusion is based on the following observations: (a) PKC activation was correlated with the increases in 1251I-albumin clearance rates for each intervention used (PMA, phospholipase C, and a-thrombin), (b) the inactive analogues of the PKC activators (4 a-phorbol didecanoate and l-mono-oleoyl glycerol) neither increased the transendothelial 125I-albumin clearance rates nor activated endothelial cell PKC, (c) inhibition of endothelial PKC using H7 significantly reduced the permeability-increasing effects of the interventions (i.e., PMA, a-thrombin, and PLC), whereas the control compound HA 1004 had no effect, (13, 22) , which was also the case in the resting bovine pulmonary artery endothelial cells used in this study. The enzyme PKC upon activation covalently binds to cell membranes where it exerts its effects (13) . Endothelial PKC activation was demonstrated as a characteristic shift in PKC activity from the cytosol to the cell membrane. In the present study, exposure ofbovine pulmonary artery endothelial cells to PMA, PLC, or a-thrombin resulted in decreases in cytosolic PKC activity and increases in covalently bound membrane-associated PKC activity, consistent with activation of the enzyme. CONTROL signal for PKC activation in many cell types. This process is catalyzed by activation of membrane phospholipase C (31), a phosphodiesterase, which hydrolyzes phosphatidylinositides to (a) diacylglycerols (which directly activate PKC [13] ) and (b) inositol phosphates (which mobilizes intracellular calcium [32, 33] ). Our results indicate that PLC increases endothelial permeability and activates PKC; moreover, the permeability increase was partially prevented by PKC inhibition. Therefore, the PLC-induced increase in permeability occurs as a consequence of increased endothelial cell phosphatidylinositide turnover and the resultant PKC activation. We examined whether a-thrombin, a mediator of coagulation and inflammation (26) , increases transendothelial permeability by the activation ofendothelial PKC. This hypothesis is based on (a) the ability of thrombin to activate PKC in platelets via a GTP-binding protein/phospholipase C-dependent mechanism (34-36), (b) our previous observation that thrombin increases transendothelial albumin permeability (3), and (c) our findings (indicated above) that phospholipase C and activators of PKC increase transendothelial '251-albumin permeability. Exposure of bovine pulmonary artery endothelial cells to a-thrombin resulted in the typical increases in endothelial permeability to '251I-albumin (3) ; but notably, this was associated with the activation of PKC. Both effects were concentration dependent. The thrombin-induced increase in permeability was partially inhibited by H7, but not by control agent HA 1004, indicating that a-thrombin-induced activation of PKC is capable of increasing endothelial permeability. However, it is likely that other thrombin-generated signals such as an increase in endothelial cytosolic Ca2`(33) are also involved, since the thrombin-mediated increase in endothelial permeability was not completely inhibited by H7.
There may be several possible mechanisms by which PKC activation can increase endothelial permeability. The effect of PKC activation may result from the phosphorylation of cytoskeletal proteins, leading to change in endothelial cell shape (37) and altered cell-cell contact (15) (16) (17) 38) . The cytoskeletal proteins vinculin, vimentin, actin, and myosin light chain are rapidly phosphorylated in response to PKC activation (38) (39) (40) . The "relaxation" ofendothelial cytoskeletal proteins mediated by phosphorylation may result in the transient disruption of interendothelial junctional complexes, and thereby, an increase in endothelial permeability. A similar mechanism may operate in epithelial cells in which PKC activation has been shown to open transiently the intercellular tight junctions (16, 17) .
In conclusion, we have shown that activation of endothelial cell PKC is an important pathway by which extracellular mediators increase transendothelial albumin transport. Phospholipase C-mediated PKC activation may be a common pathway leading to increased endothelial permeability. Such a common pathway involving PKC activation could explain the similarity in the endothelial permeability responses to a variety of inflammatory mediators.
